Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain

J. A. Lopez; A. Correa; S. Navon- Venezia; A. L. Correa; J. A. Torres; D. F. Briceño; M. C. Montealegre; J. P. Quinn; Y. Carmeli; M. V. Villegas

doi:10.1111/j.1469-0691.2010.03209.x

Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain

J. A. Lopez, A. Correa, S. Navon- Venezia, A. L. Correa, J. A. Torres, D. F. Briceño, M. C. Montealegre, J. P. Quinn, Y. Carmeli, M. V. Villegas

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Abstract

In 2008, an increase in the prevalence of carbapenem- resistant Klebsiella pneumoniae was noted in a 286- bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR- restriction fragment length polymorphism analysis and sequencing revealed bla_{KPC- 3} in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase- 3- producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase- producing pathogens.

Original language	English (US)
Pages (from-to)	52-56
Number of pages	5
Journal	Clinical Microbiology and Infection
Volume	17
Issue number	1
DOIs	https://doi.org/10.1111/j.1469-0691.2010.03209.x
State	Published - Jan 2011
Externally published	Yes

Keywords

Colombia
Dissemination
Israel
KPC- 3
Klebsiella pneumoniae

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1469-0691.2010.03209.x

Cite this

@article{38bd679bc33740069e876a38101b168c,

title = "Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain",

abstract = "In 2008, an increase in the prevalence of carbapenem- resistant Klebsiella pneumoniae was noted in a 286- bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR- restriction fragment length polymorphism analysis and sequencing revealed blaKPC- 3 in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase- 3- producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase- producing pathogens.",

keywords = "Colombia, Dissemination, Israel, KPC- 3, Klebsiella pneumoniae",

author = "Lopez, {J. A.} and A. Correa and {Navon- Venezia}, S. and Correa, {A. L.} and Torres, {J. A.} and Brice{\~n}o, {D. F.} and Montealegre, {M. C.} and Quinn, {J. P.} and Y. Carmeli and Villegas, {M. V.}",

note = "Funding Information: The conformation of the network of institutions from the Colombian Nosocomial Resistance Study Group and funding for this study were made possible thanks in part to the support of: AstraZeneca, Colombia; Pfizer Inc., Groton, CT; Merck Sharp & Dohme, Baxter, Colombia, Wyeth, Colombia,; and Janssen, Colombia. ",

year = "2011",

month = jan,

doi = "10.1111/j.1469-0691.2010.03209.x",

language = "English (US)",

volume = "17",

pages = "52--56",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain

AU - Lopez, J. A.

AU - Correa, A.

AU - Navon- Venezia, S.

AU - Correa, A. L.

AU - Torres, J. A.

AU - Briceño, D. F.

AU - Montealegre, M. C.

AU - Quinn, J. P.

AU - Carmeli, Y.

AU - Villegas, M. V.

N1 - Funding Information: The conformation of the network of institutions from the Colombian Nosocomial Resistance Study Group and funding for this study were made possible thanks in part to the support of: AstraZeneca, Colombia; Pfizer Inc., Groton, CT; Merck Sharp & Dohme, Baxter, Colombia, Wyeth, Colombia,; and Janssen, Colombia.

PY - 2011/1

Y1 - 2011/1

N2 - In 2008, an increase in the prevalence of carbapenem- resistant Klebsiella pneumoniae was noted in a 286- bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR- restriction fragment length polymorphism analysis and sequencing revealed blaKPC- 3 in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase- 3- producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase- producing pathogens.

AB - In 2008, an increase in the prevalence of carbapenem- resistant Klebsiella pneumoniae was noted in a 286- bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR- restriction fragment length polymorphism analysis and sequencing revealed blaKPC- 3 in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase- 3- producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase- producing pathogens.

KW - Colombia

KW - Dissemination

KW - Israel

KW - KPC- 3

KW - Klebsiella pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=78649654921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649654921&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2010.03209.x

DO - 10.1111/j.1469-0691.2010.03209.x

M3 - Article

C2 - 20219078

AN - SCOPUS:78649654921

SN - 1198-743X

VL - 17

SP - 52

EP - 56

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 1

ER -

Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this